KWALITY PHARMACEUTICALS
|
KWALITY PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹31 Cr | ₹26 Cr | ₹162 Cr | ₹21 Cr | ₹11 Cr |
Adjustment | ₹37 Cr | ₹21 Cr | ₹14 Cr | ₹9.09 Cr | ₹7.09 Cr |
Changes In working Capital | ₹-23 Cr | ₹1.01 Cr | ₹-73 Cr | ₹2.72 Cr | ₹-9.13 Cr |
Cash Flow after changes in Working Capital | ₹44 Cr | ₹48 Cr | ₹102 Cr | ₹33 Cr | ₹8.87 Cr |
Cash Flow from Operating Activities | ₹43 Cr | ₹41 Cr | ₹61 Cr | ₹27 Cr | ₹6.16 Cr |
Cash Flow from Investing Activities | ₹-26 Cr | ₹-48 Cr | ₹-63 Cr | ₹-23 Cr | ₹-18 Cr |
Cash Flow from Financing Activities | ₹-17 Cr | ₹0.99 Cr | ₹5.66 Cr | ₹0.77 Cr | ₹12 Cr |
Net Cash Inflow / Outflow | ₹-0.81 Cr | ₹-6.07 Cr | ₹3.33 Cr | ₹4.27 Cr | ₹0.14 Cr |
Opening Cash & Cash Equivalents | ₹3.07 Cr | ₹9.13 Cr | ₹5.81 Cr | ₹1.54 Cr | ₹1.40 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹2.26 Cr | ₹3.07 Cr | ₹9.13 Cr | ₹5.81 Cr | ₹1.54 Cr |
Compare Cashflow Statement of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹785.7 Cr | -1.6% | -15.3% | 65.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,784.6 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | -1.6% |
-15.3% |
65.2% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses